SUMMARY OF PRODUCT CHARACTERISTICS
|
|
- Jean Bryant
- 6 years ago
- Views:
Transcription
1 1 NAME OF THE MEDICINAL PRODUCT YOCON-GLENWOOD Tablets 5 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains 5 mg yohimbine hydrochloride. For a full list of excipients, see section PHARMACEUTICAL FORM Tablets 4 CLINICAL PARTICULARS 4.1 Therapeutic Indications Supportive treatment of mild to moderate erectile dysfunction within the frame of other therapeutic measures against impotence 4.2 Posology, method of administration It is recommended to begin therapy with 2 times 1 tablet per day and increase dosage if required and well tolerated stepwise to a maximum of 2 tablets 3 times daily. The tablets should be taken with some water after the meal. Therapy duration is usually about 8 weeks. There is a general latency period of 2-3 weeks until onset of action. In case of undesirable effects dosage should be reduced or medication discontinued. Administration in patients with impaired liver and/or renal function Patients with mild to moderately impaired liver and/or renal function should use YOCON-GLENWOOD with caution (see 4.4 Special warnings ). In patients with severely impaired liver and/or renal function administration of YOCON-GLENWOOD is contraindicated (see 4.3. Contraindications ). Administration in elderly patients Special safety or efficacy tests of yohimbine HCl were not performed in elderly patients. Administration in children and adults YOCON-GLENWOOD is not indicated in patients below 18 years. Administration in women YOCON-GLENWOOD is not indicated for sexual dysfunction in women. 4.3 Contraindications Heart diseases (especially coronary heart disease, tachyarrhythmia); Hypertension, hypotension; Severely impaired liver and/or renal function; Gastrointestinal ulcer disease; Glaucoma; Psychiatric disorder, especially affective and panic disorder; Concomitant use of central nervous acting drugs (e.g. drugs against psychiatric or neurologic disorders, some antihypertensive drugs, alcohol); page 1 von 5
2 Known hypersensitivity to any of the ingredients of YOCON-GLENWOOD. 4.4 Special warnings and precautions for use Yohimbine HCl is not recommended in erectile dysfunction due to severe organic or psychological diseases or in cases of organic clearly corrigible origin. Yohimbine-HCl may worsen an already existing dysfunction of the kidney. An impaired function of the liver may influence biotransformation of yohimbine-hcl and so enhance its clinical effects or side effects. 4.5 Interactions with other medicinal products and other form of interaction Yohimbine HCl may antagonize the action of antihypertensive drugs. yohimbine HCl and clonidine should not be administered simultaneously because their effects may neutralize each other. Concomitant medication of yohimbine HCl and tricyclic antidepressants may enhance effects and side effects of both substances. Concomitant medication of yohimbine HCl and amphetamines should be avoided because of possibly enhanced effects. Clomipramin increases plasma levels of yohimbine and may thus lead to enhanced effects. Yohimbine CHl may enhance effects of opiates. Interaction with phenothiazine is possible. Especially patients with cardiovascular risk factors should avoid concomitant intake of appetite suppressants with sibutramine. This may lead to tachycardia and hypertension. 4.6 Pregnancy and lactation For treatment of women YOCON-GLENWOOD is not indicated. 4.7 Effects on ability to drive and use machines Due to varying individual reaction the ability to drive and operate machinery while under yohimbine HCl can be impaired, notably in combination with alcohol consumption. 4.8 Undesirable effects Undesirable reactions are predominantly dose dependent and attributed to pharmacological effects of the medicament. Undesirable reactions presented below are classified according to their overall frequencies: very common ( 1/10%) common ( 1/100, < 1/100) uncommon ( 1/1.000, < 1/100) rare ( 1/10.000, < 1/1.000) very rare (< 1/10.000), not known (not assessable based on the available data) Cardiac disorders: Uncommon: increase of blood pressure, palpitations. Very rare: hypotension. Nervous system disorders: Common: headache. Uncommon: dizziness. Very rare: tremor. page 2 von 5
3 Respiratory, thoracic and mediastinal disorders: Very rare: bronchospasm. Gastrointestinal disorders: Common: nausea Uncommon: vomiting, inappetence epigastric pain diarrhoea. Renal and urinary disorders: Common: increased urinary urgency. Very rare: dysuria, decreased urinary urgency, genital pain. Skin and subcutaneous tissue disorders: Uncommon: skin flushing. Very rare: exanthema. General disorders: Uncommon: sweating, chills Immune system disorders: Uncommon: allergic reactions Psychatric disorders: Common: agitation, irritability, and sleeplessness Uncommon: nervousness 4.9 Overdose The following symptoms occurred after onetime oral intake of 200 mg yohimbine HCl: psycho-organic syndrome with anxiety, confusion, impaired coordination, epileptiform convulsions, unconsciousness, hypertension, tachycardia, vegetative disturbances, retrosternal pain, cyanosis, urinary retention, systemic lupus erythematodes. Therapy of overdose: After oral intake of high doses in an early phase detoxification by means of gastric lavage is recommended followed by administration of medicinal charcoal, and supportive medicinal therapy depending on the clinical course with: anticonvulsive therapy includes use of diazepam, phenobarbital and phenytoin; clonidine antagonizes psychovegetative symptoms; in the case of strong arousal administration of benzodiazepines. If necessary intubation, mechanical ventilation and catheterization of the bladder. 5. PHARMACOLOGICAL PROPERTIES 5.1 Pharmacodynamic properties Pharmacotherapeutic group: alpha 2 adrenergic receptor blocker ATC code: G04GE04 Yohimbine HCl is a competitive alpha 2 -adrenergic receptor blocker, acting on serotoninergic, dopaminergic and cholinergic transmitter systems. The exact mode of function in erectile dysfunction is not yet page 3 von 5
4 fully clarified. Discussed is a central nervous action, causing increased sexual desire and erection via effects on the autonomic nervous system. In addition, yohimbine HCl seems to act on dilatation of penile blood vessels and directly on penile tissue. Furthermore, it is psychoanaleptic but on the other hand it may produce anxiety. Effects on the cardiovascular system and gastrointestinal functions are rather rare. It has moderate antidiuretic activity due to possible release of ADH (antidiuretic hormone). 5.2 Pharmacokinetic properties Yohimbine HCl is completely absorbed within about an hour. Maximum blood levels are reached after min. Bioavailability varies a lot both inter- and intraindividually, predominantly due to an hepatic firstpass effect. Distribution of yohimbine HCl indicates a high tissue-binding capacity. Yohimbine shows plasma binding to protein of about 82 %. Only a small amount of yohimbine as well as the active metabolite 11-hydroxy yohimbine are detectable in liquor. Elimination occurs via hepatic as well as extrahepatic metabolic pathways. Two hydroxylated metabolites could be established, 11-hydroxyyohimbine and 10 hydroxyyohimbine. Elimination half life varies between 0,25 and 2,5 hours after single dose. The active metabolite 11- hydroxyyohimbine is eliminated at a higher half-life of about 6 hours. 5.3 Preclinical safety data Symptoms of an acute yohimbine intoxication are described in chapter 4.9. Very limited preclinical data regarding chronic toxicity show no specific organ damage in rats, nevertheless a dose dependant disturbance of weight gain has been observed. In vitro and in vivo examinations regarding the genotoxic potential of yohimbine were negative. Yohimbine showed no effect on fertility or reproductive behaviour of male rats as a result of a fertility study. At a dose above 6 mg/kg body weight diminished weights of testes and epididymides have been observed. 6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Calcium hydrogen phosphate dihydrate, povidone K 25, microcrystalline cellulose maize starch, colloidal anhydrous silica, magnesium stearate (Ph.Eur) 6.2 Incompatibilities Not known. 6.3 Shelf life 3 years 6.4 Special precautions for storage Do not store above 25 C. Store in the original package. 6.5 Nature and content of container Blister strips made of PVC / aluminium foil in folding cartons with 50 or 100 tablets page 4 von 5
5 6.6 Special precautions for disposal and other handling Not applicable. 7. MARKETING AUTHORISATION HOLDER GLENWOOD GmbH Postfach D Starnberg Riedener Weg 23 D Starnberg Tel.: +49 (0) info@glenwood.de 8. MAREKTING AUTHORISATION NUMBER DATE OF RENEWAL OF THE AUTHORISATION DATE OF REVISION OF THE TEXT February PRESCRIPTION REQUIREMENT STATUS Prescription only page 5 von 5
NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.
1. PRODUCT NAME ACUPAN 30 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nefopam hydrochloride 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cyklo-f 500 mg film coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One tablet contains tranexamic acid 500 mg For the full
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cyklonova 500 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Tranexamic acid 500 mg. For the full list of excipients,
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Telfast 120 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 120 mg of fexofenadine hydrochloride,
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fexofenadine hydrochloride 180 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 180mg
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT {To be completed nationally} 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 mg tablets: each tablet contains 1 mg granisetron (as hydrochloride).
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One orodispersible
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME Sudomyl, Tablet, 60 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substance Pseudoephedrine Hydrochloride 60mg Excipient(s) with known effect For the full
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Fexofenadine Cipla 120 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 120 mg fexofenadine
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Colecalciferol Meda 800 IU tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains colecalciferol (vitamin D 3 ) 800 IU
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Atrosan Devil's Claw film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 480 mg of extract
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Comfora 595 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains: glucosamine sulphate
More information1. NAME OF THE MEDICINAL PRODUCT. Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1. NAME OF THE MEDICINAL PRODUCT Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Oxymetazoline hydrochloride 0.5 mg/ml 1 spray (50 l) contains approximately 25
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT ALVERINE Mayoly Spindler, 60 mg hard capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 60 mg of alverine citrate.
More informationNEW ZEALAND DATA SHEET
NEW ZEALAND DATA SHEET VERGO 16 1. Product Name Vergo 16, 16 mg, tablet. 2. Qualitative and Quantitative Composition Each tablet contains 16 mg of betahistine dihydrochloride. For the full list of excipients,
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Otrivin Menthol (without preservative) 1.0 mg/ml nasal spray, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 1.0 mg
More informationAUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM
AUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 1 NAME OF THE MEDICINE Betahistine dihydrochloride. 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM
More informationEmergency contraception is an occasional method. It should in no instance replace a regular contraceptive method.
1. NAME OF THE MEDICINAL PRODUCT: Levonorgestrel Tablets 1.5 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION: Each tablet contains levonorgestrel 1.5 mg. Excipient with known effect: Each tablet contains
More information3 PHARMACEUTICAL FORM Coated tablet Round, white to off-white, sugar coated tablets, plain on both sides.
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Mebeverine hydrochloride 135 mg coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each coated tablet contains 135 mg of mebeverine
More informationPRODUCT INFORMATION LEAFLET
PRODUCT INFORMATION LEAFLET 1. Product Name Brand Name: Crocin Cold & Flu Max Generic Name: Paracetamol, Caffeine and Phenylephrine Hydrochloride Tablets 2. Qualitative & Quantitative Composition Each
More informationPRODUCT INFORMATION. (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
NORGESIC Orphenadrine citrate and paracetamol PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Chemical name: CAS number: 4682-36-4 Chemical structure: Orphenadrine citrate (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine
More informationPART IB : SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT GUTRON QUALITATIVE AND QUANTITATIVE COMPOSITION
1 PART IB : SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT GUTRON 2.5 2. QUALITATIVE AND QUANTITATIVE COMPOSITION For each tablet 2,5 mg midodrine hydrochloride. For excipients see
More informationSUMMARY OF PRODUCT CHARACTERISTICS
MUTUAL RECOGNITION PROCEDURE Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT, syrup 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of syrup contains 1 mg loratadine.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ketosteril film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains: (RS)-3-methyl-2-oxovaleric
More informationKetosteril. Total nitrogen content per tablet
1. NAME OF THE MEDICINAL PRODUCT Ketosteril film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains: (RS)-3-methyl-2-oxovaleric acid (α-ketoanalogue to DL-isoleucine),
More informationSANDOMIGRAN (pizotifen malate)
SANDOMIGRAN (pizotifen malate) S N CH 3 Pizotifen. COOH CH OH CH 2 COOH MALATE DESCRIPTION Pizotifen is a cycloheptathiophene derivative structurally related to cyproheptadine and the tricyclic antidepressants.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Alfuzosin HCl Ranbaxy 10 mg tablets, prolonged-release tablets. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Desmopressin acetate 0.2 mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 0.2 mg desmopressin acetate tablet corresponds to
More informationPRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets
PRODUCT INFORMATION SUDAFED Sinus 12 Hour Relief Tablets NAME OF THE MEDICINE Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 DESCRIPTION SUDAFED Sinus 12 Hour Relief prolonged-release tablets
More informationLACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION
LACIPIL lacidipine QUALITATIVE AND QUANTITATIVE COMPOSITION Lacidipine, 2 mg - round shaped white engraved on one face. Lacidipine, 4 mg - oval white with break line on both faces. Lacidipine, 6 mg - oval
More informationSUMMARY OF THE PRODUCT CHARACTERISTICS
SUMMARY OF THE PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Xatral OD 10 mg prolonged-release tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged-release tablet contains Alfuzosin
More informationBody weight more than 30kg : 10ml (10mg) of the syrup once daily.
1. Name of the medicinal product Clarityn Allergy 1mg/ml Syrup 2. Qualitative and quantitative composition Each ml of syrup contains 1mg loratadine. Excipients with known effect. The quantity of sucrose
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Desunin 4000 IU Tablets Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains colecalciferol (vitamin D 3 ) 4000 IU (equivalent
More informationFixed combination of Valeriana officinalis L., radix (valerian root) and Humulus lupulus L., flos (hop strobile).
SUMMARY OF PRODCUT CHARACTERISTICS (SmPC) 1. NAME OF THE MEDICINAL PRODUCT Dorminol Night film coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Fixed combination of Valeriana officinalis L., radix
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Citanest with Octapressin Dental 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains Prilocaine Hydrochloride 30 mg (54 mg/1.8
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Clomicalm 5 mg tablets for dogs Clomicalm 20 mg tablets for dogs Clomicalm 80 mg tablets for dogs 2. QUALITATIVE
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Procto-Glyvenol, 400 mg + 40 mg, suppository Procto-Glyvenol, 5% + 2%, rectal cream 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One suppository
More information100 ml of the syrup contain 825 mg of ivy leaf dry extract (Hedera helix L., folium) ( 4-8:1). Extraction solvent: ethanol 30% (m/m).
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Hedussin syrup 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 100 ml of the syrup contain 825 mg of ivy leaf dry extract (Hedera helix L.,
More informationMARKETING AUTHORISATION NO. 403/2007/01-02 Annex 2 Summary of Product Characteristics
Pyrazinamide 500mg tablets ( Antibiotice S. A. ), TB267 WHOPAR part 4 supplier s translation of the text as approved by the stringent regulatory authority June 2014 MARKETING AUTHORISATION NO. 403/2007/01-02
More informationOff-white, round, with faceted edges, scored on one side and bearing the inscription IK10 (10mg) or IK20 (20mg).
1 TRADE NAME OF THE MEDICINAL PRODUCT Ikorel 10mg and 20mg Tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Nicorandil 10mg or 20mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT "Carbellon" Tablets. 2. Qualitative and Quantitative Composition Active Constituents: Activated Charcoal Ph.Eur. Magnesium Hydroxide Ph.Eur.
More informationVALERIANA OFFICINALIS 445 MG COATED TABLET Summary of Product Characteristics
Sandoz Business use only Page 1 of 5 Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT Valeriaan Sandoz omhulde tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each coated tablet contains
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Betahistine
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Betahistine
More informationLEAFLET: INFORMATION FOR THE USER. Freshalgin 500th mg tablets Metamizole sodium (M etamizol sodium)
LEAFLET: INFORMATION FOR THE USER Freshalgin 500th mg tablets Metamizole sodium (M etamizol sodium) Read this leaflet carefully before you start taking this medicine. This medicine is available without
More informationSummary of Product Characteristics
TRANSLATION FROM LATVIAN Summary of Product Characteristics State Agency of Medicines, Director I.Adoviča /signature/ Registered No.10843-300708 1. NAME OF THE MEDICINAL PRODUCT ADAPTOL 500 mg Tabletes
More informationDimaval (DMPS) 100 mg Hartkapseln
SUMMARY OF PRODUCT CHARACTERISTICS Dimaval (DMPS) 100 mg Hartkapseln 1. NAME OF THE MEDICINAL PRODUCT Dimaval (DMPS) 100 mg Hartkapseln 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 hard capsule contains
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 6 1. Name of the Medicinal Product Cycloserine 250mg Capsules 2. Qualitative and Quantitative Composition Each hard capsule contains: Cycloserine 250 mg For
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lacidipine 2 mg Film-Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2 mg lacidipine. Excipient with known
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Omnilax 10 g powder for oral solution, sachet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One sachet contains 10 g of macrogol 4000.
More informationSUMMARY OF PRODUCT CHARACTERISTICS. A 2.5ml single-dose bottle containing IU Cholecalciferol (equivalent to 625 micrograms vitamin D 3 )
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fultium 25 000 IU Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION A 2.5ml single-dose bottle containing 25 000 IU Cholecalciferol
More informationNevirapine 200mg Tablet WHOPAR part 4 May 2005 Section 7 updated: May 2016 SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Nevirapine 200mg Tablet. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nevirapine 200 mg. For excipients, see section
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 80mg Suppositories 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 80mg Paracetamol For a full list of
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lidokain Isdin 40 mg/g cream 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g cream contains 40 mg lidocaine. Excipients: Propylene glycol
More informationPackage Insert. Clistin Dry. 24 hours.
Package Insert Clistin Dry Product Summary 1. Name of the medicinal product Clistin Dry 2. Qualitative and quantitative composition Dextromethorphan Hbr 10 mg Chlorpheniramine Maleate 2 mg Phenylephrine
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT INCURIN 1 mg tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ondansetron Aristo 4 mg film-coated tablets Ondansetron Aristo 8 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Diclofenac Orifarm, 11.6 mg/g gel. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 gram Diclofenac Orifarm gel contains 11.6 mg (1.16%)
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SimAlvia 60 mg/300 mg, soft capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each soft capsule contains 60 mg alverine citrate and
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection. Ephedrine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER EPHEDRINE HCl STEROP 10mg/ml EPHEDRINE HCl STEROP 50mg/ml Solution for injection Ephedrine Hydrochloride Read all of this leaflet carefully before you start using
More informationDomperidon Betapharm 10 mg tablets. Summary of Product Characteristics. 1:(to be changed into local product name in each CMS after day 90)
1. NAME OF THE MEDICINAL PRODUCT Domperidone Betapharm10 mg, tablets 1 Summary of Product Characteristics 1:(to be changed into local product name in each CMS after day 90) 2. QUALITATIVE AND QUANTITATIVE
More informationAVIOMARIN 50 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER AVIOMARIN 50 mg tablets DIMENHYDRINATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationNew Zealand Datasheet. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Bicalutamide 50 mg film coated tablets
New Zealand Datasheet 1 PRODUCT NAME Binarex 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Bicalutamide 50 mg film coated tablets 3 PHARMACEUTICAL FORM Binarex tablets are white to off-white, circular, biconvex,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 50 mg/ml solution for injection for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PT, RO,
More informationTranslated from Latvian Approved by SAM on
Translated from Latvian SAM on 29.07.2010 1. NAME OF THE MEDICINAL PRODUCT FENKAROL 10 mg Tablets FENKAROL 25 mg Tablets FENKAROL 50 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance
More informationSummary of Product Characteristics
Translation from Latvian Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT Neiromidin 20 mg tablets Neiromidin 5 mg/ml solution for injection Neiromidin 15 mg/ml solution for injection
More informationPackage Insert. Cognitin
Package Insert Cognitin Product Summary 1. Name of the medicinal product Cognitin 2. Qualitative and quantitative composition Each film coated tablet contains extract 60 mg 5mg 3. Pharmaceutical form Film
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Calvepen 666 mg Tablets. Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 666 mg of Phenoxymethylpenicillin Calcium equivalent
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT STRIVIT-D3 3,200 IU Capsules, Soft 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 3,200 IU Colecalciferol (equivalent
More informationSUMMARY OF PRODUCT CHARACTERISTICS. One film-coated tablet contains 10 mg of cetirizine dihydrochloride.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cetirizin STADA 10 mg, film-coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains 10 mg of cetirizine
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Alfuzosin Stada 5 mg prolonged-release tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg alfuzosin hydrochloride.
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each capsule contains PARACETAMOL 500mg For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PARACETAMOL 500mg CAPSULES Boots Paracetamol 500mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains PARACETAMOL
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 100 mg of trimethoprim. For the full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Trimethoprim 100 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 100 mg of trimethoprim. For the full list
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Metformin HCl Bluefish 500 mg, film-coated tablets Metformin HCl Bluefish 850 mg, film-coated tablets Metformin HCl Bluefish 1000 mg,
More informationPhysiotens 0.2 mg Abbott
10-14 Physiotens 0.2 mg Abbott Film-coated tablets 0.2 mg moxonidine Physiotens 0.2 mg tablets are round, convex, light pink, film-coated tablets with the stamp «0.2» on one face. Each tablet contains
More informationLEAFLET: INFORMATION FOR THE USER. Gutron 2,5 mg Tablet. Midodrine hydrochloride
LEAFLET: INFORMATION FOR THE USER Gutron 2,5 mg Tablet Midodrine hydrochloride Read this leaflet carefully before taking this medicine. - Keep this leaflet. You may need to read it again. - If you have
More informationNEW ZEALAND DATASHEET
NEW ZEALAND DATASHEET COLDREX HOT REMEDY COLD & FLU HOT LEMON Powder for Oral Solution Paracetamol (BP) 1000mg/sachet Presentation Pale yellow, free flowing heterogeneous powder with and odour of lemon
More informationSUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium).
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT [XXX] 500 mg chewable tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One chewable tablet contains 1250 mg calcium carbonate (equivalent
More informationNAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.
NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon-A contains naphazoline hydrochloride
More information1. NAME OF THE MEDICINAL PRODUCT. Lamisil 1% cutaneous solution. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1. NAME OF THE MEDICINAL PRODUCT Lamisil 1% cutaneous solution. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: 10 mg terbinafine hydrochloride per 1 g solution (1% w/w). Excipient(s) with
More informationArticle 30 Referral for Calcitugg (and associated names) Chewable tablets (Calcium carbonate)
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS, PACKAGING AND PACKAGE SIZES OF THE MEDICINAL PRODUCT IN THE MEMBER STATES 1 Article
More informationSUMMARY OF THE PRODUCT CHARACTERISTICS. The content of electrolyte ions per sachet when made up to 125 ml of solution.
SUMMARY OF THE PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Molaxole powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains following active substances Macrogol
More informationSummary of Product Characteristics
Summary of Product Characteristics This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Lopacut 2 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2 mg of loperamide hydrochloride. For
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Reconcile 8 mg chewable tablets for dogs Reconcile 16mg chewable tablets for dogs Reconcile 32 mg chewable tablets
More informationSummary of Product Characteristics
Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT Terbinafine Dermapharm, 10 mg/g, cream 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One gram of cream contains 10 mg of terbinafine hydrochloride.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Calcium Sandoz 500 mg, effervescent tablets Calcium Sandoz 1000 mg, effervescent tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationData Sheet. BICALOX 50 mg is a white to off-white, round, film coated, biconvex tablets, engraved with 'BC 50' on one face and plain on the other.
BICALOX Data Sheet Bicalutamide 50 mg tablets Presentation BICALOX 50 mg is a white to off-white, round, film coated, biconvex tablets, engraved with 'BC 50' on one face and plain on the other. Uses Actions
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Prostasan soft capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 320 mg of extract (as soft extract) from Serenoa
More informationFor the use only of a Registered Medical Practitioner or a Hospital or a Laboratory. Light Liquid Paraffin and White Soft Paraffin Cream
For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory OILATUM CREAM / KIDS CREAM Light Liquid Paraffin and White Soft Paraffin Cream QUALITATIVE AND QUANTITATIVE COMPOSITION
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Albunorm 5%, 50 g/l, solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Albunorm 5% is a solution containing 50 g/l of total
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 20 mg chewable tablets for dogs (AT, BE, BG, CY, CZ, DE, EL, ES, HR, HU, IE, IT, LU, NL, PL, PT, RO, SI,
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Attia 200 mg Modified-Release Capsules, Hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each modified-release capsule contains dipyridamole
More informationPackage leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin
Package leaflet: Information for the patient Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Read all of this leaflet carefully before you start taking this medicine because it contains
More informationNAME OF THE MEDICINAL PRODUCT IMODIUM CAPS. QUALITATIVE AND QUANTITATIVE COMPOSITION 2 mg loperamide hydrochloride (HCl) per capsule.
NAME OF THE MEDICINAL PRODUCT IMODIUM CAPS QUALITATIVE AND QUANTITATIVE COMPOSITION 2 mg loperamide hydrochloride (HCl) per capsule. PHARMACEUTICAL FORM AND DESCRIPTION Capsules, hard White powder filled
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Isosorbidmononitrat Mylan 60 mg Prolonged-release Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each prolonged-release tablet contains
More information